|
ALLIANCE-MM1MDS-A01
Phase II
OPEN TO ACCRUAL
|
|
BEONE-BG-75098-101
Phase I
OPEN TO ACCRUAL
|
|
CTN-2203
Phase III
OPEN TO ACCRUAL
|
|
DAIICHI-SANKYO-DS3201-343
Phase I
OPEN TO ACCRUAL
|
|
DAIICHI-SANKYO-DS3939-077
Phase I/II
OPEN TO ACCRUAL
|
|
ECOG-EA4232
Phase III
OPEN TO ACCRUAL
|
|
ECOG-EA7222
Phase III
OPEN TO ACCRUAL
|
|
IIT-AKHTAR-CILTA-TALQ
Phase I
OPEN TO ACCRUAL
|
|
INCYTE-INCA035784-101
Phase I
OPEN TO ACCRUAL
|
|
INNOCARE-ICP-CL-01205
Phase I
OPEN TO ACCRUAL
|
|
KURA-KO-MEN-015
Phase I
OPEN TO ACCRUAL
|
|
KURA-KO-MEN-017
Phase III
OPEN TO ACCRUAL
|
|
MERCK-MK2140-011-00
Phase II
OPEN TO ACCRUAL
|
|
MODERNA-MRNA-2808-P101
Phase I/II
OPEN TO ACCRUAL
|
|
NOVARTIS-CABL001A2001B
Phase IV
OPEN TO ACCRUAL *
|
|
PFIZER-C1071030
Phase I
OPEN TO ACCRUAL
|
|
STEMLINE-MEN2312-01
Phase I
OPEN TO ACCRUAL
|
|
SWOG-MM1OA-S03
Phase II
OPEN TO ACCRUAL
|
|
SWOG-MM1YA-S01
Phase II
OPEN TO ACCRUAL
|
|
TERREMOTO-TER-2013-C01
Phase I/II
OPEN TO ACCRUAL
|
|
TEVA-TV56278-ONC-10203
Phase I
OPEN TO ACCRUAL
|
|
1
| |
|
2
| |
2
| |
3
| |
|
|
| |
1
| |
|
1
| |
| |
|
2
| |
8
| |
CARIBOU-CAMMOUFLAGE-CB-011A-MM
Phase I
OPEN TO ACCRUAL
| |
CELGENE-GC-LTFU-001
Phase II/III
OPEN TO ACCRUAL
| |
GRACELL-GC012F-CD19-BCMA-001
Phase I/II
OPEN TO ACCRUAL
| |
GSK-3377794-LTFU
Phase I
OPEN TO ACCRUAL
| |
IIT-SHAH-IL7-IL15-CD20-19
Phase I/II
OPEN TO ACCRUAL
| |
JNJ-MY4002-CARTINUE-LTFU
Phase IV
OPEN TO ACCRUAL
| |
NEOGENE-NT-112-301
Phase I
OPEN TO ACCRUAL
| |
NEOGENE-NT-175-201
Phase I
OPEN TO ACCRUAL
|
|
| |
| |
1
| |
1
| |
|
1
|
|
| |
| |
| |
|
3
|
| |
1
| |
|
| |
|
|
2
|
2
| |
1
| |
|
1
| |
|
| |
2
|
|
| |
1
|
| |
|
|
1
| |
4
|
| |
5
| |
|
1
| |
|
1
|
|
| |
| |
|
|
|
1
| |
|
1
| |
2
| |
3
|
| |
2
| |
|
1
| |
|
|
1
|
| |
2
| |
| |
|
|
| |
2
| |
|
1
| |
|
6
| |
9
| |
1
| |
IIT-GEORGE-I-PREDICT
Phase I/II
OPEN TO ACCRUAL
|
|
1
| |
ALLIANCE-A151804
Phase N/A
OPEN TO ACCRUAL
|
|